Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harold Atkins

Showing results (11-20 of 76) with videos related to

Pageof 8
Sort By:
Hematology, Transfusion and Cell Therapy|September 24, 2020
Cyclophosphamide-glucocorticoids versus lenalidomide-dexamethasone as treatment for multiple myeloma at first relapse after autologous stem cell transplantation - a retrospective analysisRussell Sterrett, Amarilis Figueiredo, Ranjeeta Mallick, et al.
Systematic Reviews|January 22, 2021
Efficacy and safety of CD22 chimeric antigen receptor (CAR) T cell therapy in patients with B cell malignancies: a protocol for a systematic review and meta-analysisKomal Adeel, Nathan J Fergusson, Risa Shorr, et al.
Hematology, Transfusion and Cell Therapy|August 16, 2019
The impact of multiple myeloma induction therapy on hematopoietic stem cell mobilization and collection: 25-year experienceAmarilis Figueiredo, Rabih Kassis, Rashed Albacker, et al.
Current Oncology (Toronto, Ont.)|August 28, 2024
Phase-Based and Lifetime Health System Costs of Care for Patients Diagnosed with Leukemia and Lymphoma: A Population-Based Descriptive StudyAnubhav Agarwal, Natasha Kekre, Harold Atkins, et al.
Muscle & Nerve|December 17, 2022
Autologous hematopoietic stem cell transplant for the treatment of refractory myasthenia gravis with anti-muscle specific kinase antibodiesBenjamin Beland, Christopher Hahn, Kareem Jamani, et al.
Cytokine & Growth Factor Reviews|March 27, 2010
Double trouble for tumours: exploiting the tumour microenvironment to enhance anticancer effect of oncolytic virusesNaomi De Silva, Harold Atkins, David H Kirn, et al.
Molecular Genetics and Metabolism Reports|July 29, 2025
Outcome of two siblings with late-onset Krabbe disease following allogeneic hematopoietic stem cell transplantation: And review of literatureMontaha Almudhry, Chitra Prasad, Keng Yow Tay, et al.
Current Protocols|May 20, 2022
Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis, the Ottawa ProtocolMathieu Puyade, Francis Brunet, Rush Carolina, et al.
BMC Biotechnology|October 5, 2013
A method for cell type marker discovery by high-throughput gene expression analysis of mixed cell populationsMiguel A Andrade-Navarro, Femina Kanji, Carmen G Palii, et al.
International Journal of Laboratory Hematology|June 17, 2020
Importance of the hematology laboratory in infectious disease diagnosis by morphology: Four educational case studiesRuth F Padmore, Luke R Shier, Aleksandra Paliga, et al.
Pageof 8

Showing results (11-20 of 76) with videos related to

Sort By:
Pageof 8
Hematology, Transfusion and Cell Therapy|September 24, 2020
Cyclophosphamide-glucocorticoids versus lenalidomide-dexamethasone as treatment for multiple myeloma at first relapse after autologous stem cell transplantation - a retrospective analysisRussell Sterrett, Amarilis Figueiredo, Ranjeeta Mallick, et al.
Systematic Reviews|January 22, 2021
Efficacy and safety of CD22 chimeric antigen receptor (CAR) T cell therapy in patients with B cell malignancies: a protocol for a systematic review and meta-analysisKomal Adeel, Nathan J Fergusson, Risa Shorr, et al.
Hematology, Transfusion and Cell Therapy|August 16, 2019
The impact of multiple myeloma induction therapy on hematopoietic stem cell mobilization and collection: 25-year experienceAmarilis Figueiredo, Rabih Kassis, Rashed Albacker, et al.
Current Oncology (Toronto, Ont.)|August 28, 2024
Phase-Based and Lifetime Health System Costs of Care for Patients Diagnosed with Leukemia and Lymphoma: A Population-Based Descriptive StudyAnubhav Agarwal, Natasha Kekre, Harold Atkins, et al.
Muscle & Nerve|December 17, 2022
Autologous hematopoietic stem cell transplant for the treatment of refractory myasthenia gravis with anti-muscle specific kinase antibodiesBenjamin Beland, Christopher Hahn, Kareem Jamani, et al.
Cytokine & Growth Factor Reviews|March 27, 2010
Double trouble for tumours: exploiting the tumour microenvironment to enhance anticancer effect of oncolytic virusesNaomi De Silva, Harold Atkins, David H Kirn, et al.
Molecular Genetics and Metabolism Reports|July 29, 2025
Outcome of two siblings with late-onset Krabbe disease following allogeneic hematopoietic stem cell transplantation: And review of literatureMontaha Almudhry, Chitra Prasad, Keng Yow Tay, et al.
Current Protocols|May 20, 2022
Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis, the Ottawa ProtocolMathieu Puyade, Francis Brunet, Rush Carolina, et al.
BMC Biotechnology|October 5, 2013
A method for cell type marker discovery by high-throughput gene expression analysis of mixed cell populationsMiguel A Andrade-Navarro, Femina Kanji, Carmen G Palii, et al.
International Journal of Laboratory Hematology|June 17, 2020
Importance of the hematology laboratory in infectious disease diagnosis by morphology: Four educational case studiesRuth F Padmore, Luke R Shier, Aleksandra Paliga, et al.
Pageof 8